Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean P Gavan

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
BMC Rheumatology|January 1, 2020
Factors that influence rheumatologists' anti-tumor necrosis factor alpha prescribing decisions: a qualitative studySean P Gavan, Gavin Daker-White, Katherine Payne, et al.
Pharmacoeconomics|March 11, 2023
Capturing the Impact of Constraints on the Cost-Effectiveness of Cell and Gene Therapies: A Systematic ReviewSean P Gavan, Stuart J Wright, Fiona Thistlethwaite, et al.
Rheumatology Advances in Practice|September 11, 2020
Therapeutic monitoring of TNF inhibitors for rheumatoid arthritis: evidence required following NICE's recommendationsSean P Gavan, Meghna Jani, James Bluett, et al.
Nature Reviews. Genetics|January 23, 2018
Cost-effectiveness analyses of genetic and genomic diagnostic testsKatherine Payne, Sean P Gavan, Stuart J Wright, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 24, 2019
The role of information provision in economic evaluations of non-invasive prenatal testing: a systematic reviewNikita M John, Stuart J Wright, Sean P Gavan, et al.
Frontiers in Transplantation|August 30, 2024
An analysis of the UK national pancreas allocation schemeJeevan Prakash Gopal, Sean P Gavan, Kerry Burke, et al.
Health Economics Review|September 30, 2025
Primary endocrine therapy versus surgery plus endocrine therapy for early-stage breast cancer in older women without frailty: a cost-effectiveness and value of implementation analysisYubo Wang, Li-Chia Chen, Kwok-Leung Cheung, et al.
Cost Effectiveness and Resource Allocation : C/E|March 2, 2022
Systematic review of the evidence sources applied to cost-effectiveness analyses for older women with primary breast cancerYubo Wang, Sean P Gavan, Douglas Steinke, et al.
Health and Quality of Life Outcomes|December 23, 2022
The impact of age on health utility values for older women with early-stage breast cancer: a systematic review and meta-regressionYubo Wang, Sean P Gavan, Douglas Steinke, et al.
British Journal of Clinical Pharmacology|April 29, 2022
Does coprescribing nonsteroidal anti-inflammatory drugs and oral anticoagulants increase the risk of major bleeding, stroke and systemic embolism?Leonie S Penner, Sean P Gavan, Darren M Ashcroft, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
BMC Rheumatology|January 1, 2020
Factors that influence rheumatologists' anti-tumor necrosis factor alpha prescribing decisions: a qualitative studySean P Gavan, Gavin Daker-White, Katherine Payne, et al.
Pharmacoeconomics|March 11, 2023
Capturing the Impact of Constraints on the Cost-Effectiveness of Cell and Gene Therapies: A Systematic ReviewSean P Gavan, Stuart J Wright, Fiona Thistlethwaite, et al.
Rheumatology Advances in Practice|September 11, 2020
Therapeutic monitoring of TNF inhibitors for rheumatoid arthritis: evidence required following NICE's recommendationsSean P Gavan, Meghna Jani, James Bluett, et al.
Nature Reviews. Genetics|January 23, 2018
Cost-effectiveness analyses of genetic and genomic diagnostic testsKatherine Payne, Sean P Gavan, Stuart J Wright, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 24, 2019
The role of information provision in economic evaluations of non-invasive prenatal testing: a systematic reviewNikita M John, Stuart J Wright, Sean P Gavan, et al.
Frontiers in Transplantation|August 30, 2024
An analysis of the UK national pancreas allocation schemeJeevan Prakash Gopal, Sean P Gavan, Kerry Burke, et al.
Health Economics Review|September 30, 2025
Primary endocrine therapy versus surgery plus endocrine therapy for early-stage breast cancer in older women without frailty: a cost-effectiveness and value of implementation analysisYubo Wang, Li-Chia Chen, Kwok-Leung Cheung, et al.
Cost Effectiveness and Resource Allocation : C/E|March 2, 2022
Systematic review of the evidence sources applied to cost-effectiveness analyses for older women with primary breast cancerYubo Wang, Sean P Gavan, Douglas Steinke, et al.
Health and Quality of Life Outcomes|December 23, 2022
The impact of age on health utility values for older women with early-stage breast cancer: a systematic review and meta-regressionYubo Wang, Sean P Gavan, Douglas Steinke, et al.
British Journal of Clinical Pharmacology|April 29, 2022
Does coprescribing nonsteroidal anti-inflammatory drugs and oral anticoagulants increase the risk of major bleeding, stroke and systemic embolism?Leonie S Penner, Sean P Gavan, Darren M Ashcroft, et al.
Pageof 4